The FDA approves a new prevention therapy for chronic migraine. @Molly O’Brien will fill you in on the latest migraine news in this week’s Migraine Minute. Follow @migrainedisorders to catch these updates.

More info:

https://news.abbvie.com/news/press-releases/us-fda-approves-qulipta-atogepant-for-adults-with-chronic-migraine.htm